SIRPB2 Antibody (1008702) [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # FAB99981D
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG2B Clone # 1008702
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
HEK293 human embryonic kidney cell line, HEK293 derived Human SIRP beta 2
Gln33-Gly287
Accession # Q5JXA9
Gln33-Gly287
Accession # Q5JXA9
Specificity
Detects human SIRP beta 2 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for SIRPB2 Antibody (1008702) [DyLight 350]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: SIRP beta 2
Long Name
Signal-regulatory Protein beta 2
Alternate Names
PTPN1L, PTPNS1L3
Additional SIRP beta 2 Products
Product Documents for SIRPB2 Antibody (1008702) [DyLight 350]
Product Specific Notices for SIRPB2 Antibody (1008702) [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...